Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87343f0391f5074a8ffb73f681e41648 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 |
filingDate |
2013-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7a481f4e66db9a7cf3a6e3e35bc5e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a473195a93ecdbac9ba98071239812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb81df7fd7d576326df5117518a9838f |
publicationDate |
2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013203196-B2 |
titleOfInvention |
Beta-L-2'-Deoxy Nucleosides for the Treatment of Hepatitis B |
abstract |
An oral pharmaceutical unit dosage form of P-L-thymidine, wherein the dosage form comprises about 600 mg P-L-thymidine and a pharmaceutically acceptable carrier for oral delivery, wherein the dosage form is in the form of a tablet. |
priorityDate |
1998-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |